General Pediatrics

Useful in the treatment of upper and lower respiratory tract infections, skin and soft tissue infections, and bone and joint infections. Anti-infectives for systemic use Antibacterials for systemic use Beta-lactam antibacterials, penicillins Penicillin combinations, including beta-lactamase inhibitors. Bactericidal. Blocks bacterial cell wall synthesis and inhibits ß-lactamases. Broad spectrum. Mechanism of action Amoxicillin + clavulanic acid A combination of semi-synthetic penicillin (bactericidal, broad spectrum) and a ß-lactamase inhibitor molecule, transforms ß-lactamase-producing germs into amoxicillin-sensitive bacteria. Therapeutic indications Amoxicillin + clavulanic acid In adults and children, treatment. of bacterial infection by amoxicillin-resistant strains producing ß-lactamase: acute bacterial sinusitis, acute otitis media, tonsillitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, cystitis, pyelonephritis, skin and soft tissue (cellulitis, animal bites, severe dental abscesses with extended cellulitis, bones and joints (osteomyelitis), septic abortion, pelvic or puerperal sepsis, intra-abdominal sepsis. Also by IV: treatment of severe ear, nose and throat infection (mastoiditis, peritonsillar, epiglottitis and sinusitis accompanied by severe systemic symptoms), female genital, intra-abdominal, peritonitis, septicemia, and prophylaxis in ads. of infection associated with major surgery (gastrointestinal tract, pelvic cavity, head and neck, biliary tract, cardiac, renal, Joint prostheses). Extended-release tablets (1,000/62.5 mg): Community-acquired pneumonia in adults and adolescents ≥16 years of age or suspected to be caused by penicillin-resistant S. pneumoniae.

Amoxicillin is used to treat certain infections caused by bacteria, such as pneumonia, bronchitis (infection of the airways leading to the lungs), and infections of the ears, nose, throat, urinary tract, and skin. Therapeutic Indications Amoxicillin Infections caused by susceptible strains such as: throat, nose, and ear infections (tonsillitis, otitis media, sinusitis); lower respiratory tract infections (acute and chronic bronchitis, bacterial pneumonia); uncomplicated genitourinary tract infections (cystitis and urethritis); skin and soft tissue infections (including surgical wound infections); dental and oral infections; biliary tract infections; Lyme disease or borreliosis: in the treatment of early localized infection (stage 1 or localized erythema migrans) and disseminated infection or stage 2; Typhoid and paratyphoid fevers (especially indicated for the treatment of chronic biliary carriers); Helicobacter pylori eradication treatment in combination with a proton pump inhibitor (PPI) and, where appropriate, other antibiotics; peptic ulcer and low-grade gastric mucosa-associated lymphoid tissue lymphoma; prophylaxis of endocarditis caused by bacteremia following dental manipulation/extraction; treatment and prophylaxis of septicemia, endocarditis, meningitis, pyelonephritis, and certain neuropathies. WANDEL PHARMACEUTICALS, S.A. DE C.V.

Ambroxol is a mucolytic with expectorant action, which thins and facilitates the removal of bronchial secretions in patients with coughs and phlegm who need to eliminate them.

Budesonide belongs to a group of medications called glucocorticoids, which are used to reduce inflammation. Asthma is caused by inflammation of the airways. Budesonide reduces and prevents this inflammation.

Therapeutic indications Cefalexin Treatment of the following infections due to susceptible microorganisms: respiratory tract infections, otitis media, skin and subcutaneous tissue infections, urinary tract infections (including acute prostatitis) and dental infections. Mechanism of action Cefalexin Semi-synthetic antibiotic of the cephalosporin family, for oral administration. As demonstrated by in vitro tests, the bactericidal action of cephalosporins is due to the inhibition of cell wall synthesis.

Mechanism of Action Betamethasone + Loratadine It combines the anti-inflammatory and anti-allergic effects of a corticosteroid (betamethasone) with a potent, non-sedating tricyclic antihistamine with peripheral H1 receptor antagonist activity (loratadine). It is indicated for the relief of inflammatory and pruritic manifestations that characterize some atopic dermatoses, angioedema, urticaria, seasonal and perennial allergic rhinitis; food and drug allergic reactions, seborrheic dermatitis, neurodermatitis, allergic asthma, allergic ocular manifestations such as conjunctivitis and iridocyclitis, and allergic reactions to insect bites. The purpose of this combination is to eliminate inflammation through the action of betamethasone and pruritus through the action of loratadine.

Helps with respiratory ailments such as cough, phlegm, and the common cold. Pediatric use: Not recommended for children under 6 years of age.

Relief of symptoms of colds and flu-like symptoms that present with fever, mild to moderate pain, nasal congestion, and discharge. Seasonal allergic rhinitis. Allergic conjunctivitis. Vasomotor rhinitis. Useful in the treatment of mucous congestion associated with hay fever, allergic rhinitis, acute coryza, sinusitis, and other pathological respiratory allergies.

Useful in the treatment of upper and lower respiratory tract infections, skin and soft tissue infections, and bone and joint infections. Anti-infectives for systemic use. Antibacterials for systemic use. Beta-lactam antibacterials, penicillins. Penicillin combinations, including beta-lactamase inhibitors. Bactericidal. Blocks bacterial cell wall synthesis and inhibits beta-lactamases. Broad spectrum. Mechanism of action Amoxicillin + clavulanic acid A combination of a semi-synthetic penicillin (bactericidal, broad spectrum) and a beta-lactamase inhibitor makes beta-lactamase-producing bacteria susceptible to amoxicillin.

AMPIGRIN-PFC-30mlGTS-CHLORPHENAMINE-PARACETAMOL-AMANTADINE It is indicated for the treatment of influenza A virus, as it has antiviral, analgesic, antipyretic, decongestant, and antihistamine properties.

Paracetamol / Chlorphenamine / Phenylephrine. Useful in treating the symptoms of the common cold.

Mechanism of Action Dextromethorphan + Guaifenesin + Phenylephrine Dextromethorphan: dextro isomer of levorphanol, an analog of codeine. It acts centrally, depressing the medullary cough center by decreasing the production of tachykinins. The mechanism by which this effect is exerted is unknown. It has an antitussive effect similar to codeine but without narcotic effects or respiratory system disturbances. Guaifenesin: guaiacol glyceryl ether. Through an unknown mechanism, it increases the production and fluidity of bronchial secretions, facilitating their elimination. Phenylephrine: a selective β-1 adrenergic agonist responsible for its sympathomimetic effects; in this case, it is a direct-acting vasoconstrictor. Therapeutic Indications Dextromethorphan + Guaifenesin + Phenylephrine Antitussive, expectorant, and decongestant. Temporary relief of cough and nasal or sinus congestion associated with the common cold or flu. Helps to clear phlegm (mucus) and thin bronchial secretions, making coughs more productive.

Anti-diarrheal. Significantly reduces the duration and frequency of diarrhea in children and adults. Relieves painful symptoms caused by abnormal bowel movements.

It is indicated as an adjuvant in all those bronchopulmonary processes that occur with increased viscosity and adherence of mucus, in which it is necessary to keep the respiratory system free of secretions: acute bronchitis, chronic bronchitis, asthmatic bronchitis, spasmodic bronchitis, asthma. Respiratory system Cough and cold preparations Expectorants excl. associations with cough suppressants Mucolytics, Mechanism of action Ambroxol It increases secretion in the respiratory tract, enhances the production of pulmonary surfactant and stimulates ciliary activity. These actions result in an improvement in the flow and transport of mucus (mucociliary clearance), as has been demonstrated in pharmacological studies. The enhancement of fluid secretion and mucociliary clearance facilitates expectoration and relieves cough; Likewise, in patients with chronic bronchitis and/or chronic obstructive pulmonary disease (COPD), it reduces the number of relapses.

aids in the symptomatic treatment of the common cold, relieving the symptoms of this condition, such as muscle pain, runny nose and fever.

It is indicated for the treatment of influenza virus group A, including subtypes H3N2, H2N2 and H1N1, as it has specific antiviral, analgesic, antipyretic, decongestant and antihistamine action.